CompletedPhase 4

Comparison of Time to Extubation Using Sugammadex or Neostigmine

United States58 participantsStarted 2021-04-08

Plain-language summary

A prospective blinded randomized clinical trial to compare time to extubation using Sugammadex versus Neostigmine/glycopyrrolate as reversal agents after use of neuromuscular blockade agents in an outpatient bronchoscopy suite.

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. has diagnosis of COPD or ILD
✓. ASA 3 or 4
✓. procedure requires general anesthesia in the outpatient bronchoscopy suite
✓. glomerular filtration rate \> 30 ml/min

Exclusion criteria

✕. pregnant women
✕. prisoners
✕. those unable to consent for themselves
✕. procedures not requiring general anesthesia
✕. ASA 1 or 2

What they're measuring

Number of Minutes to Return of Baseline Muscle Tone

Timeframe: 1-20 minutes

Trial details

NCT IDNCT04606901

SponsorTemple University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-30

Results submitted2024-01-23

View on ClinicalTrials.gov More Neuromuscular Blockade trials